Search research articles
Contact Us
Filters
Showing results (71-80 of 348) with videos related to
Page
of 35
Sort By:
Cancers
|
July 27, 2024
Management of Metastatic Renal Cell Carcinoma Following First-Line Immune Checkpoint Therapy Failure: A Systematic Review
Fausto Petrelli, Ivano Vavassori, Mauro Rossitto, et al.
Anti-Cancer Drugs
|
March 25, 2024
Network meta-analysis of first-line systemic regimens for older patients with advanced NSCLC
Andrea Luciani, Lorenzo Dottorini, Elena Battaiotto, et al.
Tumori
|
November 22, 2021
Neoadjuvant or adjuvant immunotherapy in bladder cancer: biological opportunity or clinical utility?
Fausto Petrelli, Gianluca Perego, Ivano Vavassori, et al.
Human Vaccines & Immunotherapeutics
|
December 3, 2021
Antibody-drug conjugates in treating older patients suffering from cancer: what is the real value?
Gianluca Perego, Antonio Ghidini, Andrea Luciani, et al.
Anti-Cancer Drugs
|
October 6, 2011
Erlotinib as maintenance therapy in patients with advanced non-small cell lung cancer: a pooled analysis of three randomized trials
Fausto Petrelli, Karen Borgonovo, Mary Cabiddu, et al.
Thrombosis Research
|
October 16, 2020
Venous and arterial thromboembolic events with immune checkpoint inhibitors: A systematic review
Cinzia Solinas, Luca Saba, Paolo Sganzerla, et al.
Dermatologic Therapy
|
December 31, 2019
Role of lanreotide in an elderly patient with Merkel cell carcinoma
Antonio Ghidini, Fausto Petrelli, Ivan Fazio, et al.
BMC Cancer
|
July 6, 2016
TAS-102, the first "cardio-gentle" fluoropyrimidine in the colorectal cancer landscape?
Fausto Petrelli, Sandro Barni, Paola Bertocchi, et al.
European Journal of Clinical Pharmacology
|
June 21, 2026
A decade of progress in small-cell lung cancer (2015-2025): a narrative review
Fausto Petrelli, Lorenzo Dottorini, Antonio Ghidini, et al.
Clinical Breast Cancer
|
June 11, 2016
Vinorelbine With Capecitabine, an Evergreen Doublet for Advanced Breast Cancer: A Systematic Literature Review and Pooled-Analysis of Phase II-III Studies
Fausto Petrelli, Serena Di Cosimo, Veronica Lonati, et al.
Page
of 35
Search research articles
Search
Showing results (71-80 of 348) with videos related to
Sort By:
Page
of 35
Cancers
|
July 27, 2024
Management of Metastatic Renal Cell Carcinoma Following First-Line Immune Checkpoint Therapy Failure: A Systematic Review
Fausto Petrelli, Ivano Vavassori, Mauro Rossitto, et al.
Anti-Cancer Drugs
|
March 25, 2024
Network meta-analysis of first-line systemic regimens for older patients with advanced NSCLC
Andrea Luciani, Lorenzo Dottorini, Elena Battaiotto, et al.
Tumori
|
November 22, 2021
Neoadjuvant or adjuvant immunotherapy in bladder cancer: biological opportunity or clinical utility?
Fausto Petrelli, Gianluca Perego, Ivano Vavassori, et al.
Human Vaccines & Immunotherapeutics
|
December 3, 2021
Antibody-drug conjugates in treating older patients suffering from cancer: what is the real value?
Gianluca Perego, Antonio Ghidini, Andrea Luciani, et al.
Anti-Cancer Drugs
|
October 6, 2011
Erlotinib as maintenance therapy in patients with advanced non-small cell lung cancer: a pooled analysis of three randomized trials
Fausto Petrelli, Karen Borgonovo, Mary Cabiddu, et al.
Thrombosis Research
|
October 16, 2020
Venous and arterial thromboembolic events with immune checkpoint inhibitors: A systematic review
Cinzia Solinas, Luca Saba, Paolo Sganzerla, et al.
Dermatologic Therapy
|
December 31, 2019
Role of lanreotide in an elderly patient with Merkel cell carcinoma
Antonio Ghidini, Fausto Petrelli, Ivan Fazio, et al.
BMC Cancer
|
July 6, 2016
TAS-102, the first "cardio-gentle" fluoropyrimidine in the colorectal cancer landscape?
Fausto Petrelli, Sandro Barni, Paola Bertocchi, et al.
European Journal of Clinical Pharmacology
|
June 21, 2026
A decade of progress in small-cell lung cancer (2015-2025): a narrative review
Fausto Petrelli, Lorenzo Dottorini, Antonio Ghidini, et al.
Clinical Breast Cancer
|
June 11, 2016
Vinorelbine With Capecitabine, an Evergreen Doublet for Advanced Breast Cancer: A Systematic Literature Review and Pooled-Analysis of Phase II-III Studies
Fausto Petrelli, Serena Di Cosimo, Veronica Lonati, et al.
Page
of 35